Akeso (HKSE:09926) Days Sales Outstanding : 58.43 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Akeso Days Sales Outstanding?

Akeso's average Accounts Receivable for the six months ended in Dec. 2023 was HK$297 Mil. Akeso's Revenue for the six months ended in Dec. 2023 was HK$929 Mil. Hence, Akeso's Days Sales Outstanding for the six months ended in Dec. 2023 was 58.43.

The historical rank and industry rank for Akeso's Days Sales Outstanding or its related term are showing as below:

HKSE:09926' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.06 Med: 83.3 Max: 164.2
Current: 22.06

During the past 6 years, Akeso's highest Days Sales Outstanding was 164.20. The lowest was 22.06. And the median was 83.30.

HKSE:09926's Days Sales Outstanding is ranked better than
89.92% of 893 companies
in the Biotechnology industry
Industry Median: 72.43 vs HKSE:09926: 22.06

Akeso's Days Sales Outstanding declined from Dec. 2022 (78.58) to Dec. 2023 (58.43).

Akeso Days Sales Outstanding Historical Data

The historical data trend for Akeso's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Days Sales Outstanding Chart

Akeso Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

164.20

83.30

23.08

Akeso Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial						190.92	224.41	78.58	13.03	58.43

Competitive Comparison of Akeso's Days Sales Outstanding

For the Biotechnology subindustry, Akeso's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akeso's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Akeso's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Akeso's Days Sales Outstanding falls into.

Akeso Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Akeso's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (302.681	+	323.281)	/	2 )	/	4950.72	*	365
=	312.981					/	4950.72	*	365
=	23.08

Akeso's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (271.66	+	323.281)	/	2 )	/	929.049	*	365 / 2
=	297.4705					/	929.049	*	365 / 2
=	58.43

Akeso (HKSE:09926) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Akeso Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Akeso's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso (HKSE:09926) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (HKSE:09926) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AKESF:USA 4RY:Germany

Address

6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437

Website

https://www.akesobio.com

Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.

Akeso (HKSE:09926) Headlines

No Headlines